financetom
Business
financetom
/
Business
/
Cintas Likely to Post In-Line Fiscal Q4 Results Amid Small Business Optimism, Stable Employment Trends, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cintas Likely to Post In-Line Fiscal Q4 Results Amid Small Business Optimism, Stable Employment Trends, RBC Says
Jun 9, 2025 12:12 PM

02:56 PM EDT, 06/09/2025 (MT Newswires) -- Cintas ( CTAS ) is likely to report in-line fiscal Q4 results amid small business optimism, stable employment trends and manageable tariff headwinds, RBC Capital Markets said in a Monday note.

RBC analysts as well as analysts polled by FactSet expect the business services firm to report Q4 adjusted earnings of $1.07 per share on revenue of $2.63 billion.

RBC expects the company to provide fiscal 2026 revenue growth guidance of 6.5% to 8% and incremental margins of 25% to 35% as its four focus segments, along with first aid and fire, continue to contribute towards its growth. Also, due to technology investments by the company, it has "significant" potential for margin expansion in materials, operations, and service and distribution, the analysts said.

RBC said it expects the company to focus its capital allocation on tuck-in acquisitions and share repurchases.

RBC raised its price target on the company to $240 from $215, while maintaining a sector perform rating on the stock.

Price: 225.44, Change: -2.22, Percent Change: -0.98

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioCryst Pharmaceuticals-Astria Deal Clears Regulatory Hurdle
BioCryst Pharmaceuticals-Astria Deal Clears Regulatory Hurdle
Mar 10, 2026
07:42 AM EST, 12/03/2025 (MT Newswires) -- BioCryst Pharmaceuticals ( BCRX ) said Wednesday it received early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act with respect to the company's proposed acquisition of Astria Therapeutics. The termination satisfied one of the conditions for the deal's completion, expected in Q1, the company said. ...
Macy's lifts annual targets, strikes cautious tone about holiday spending
Macy's lifts annual targets, strikes cautious tone about holiday spending
Mar 10, 2026
* Macy's notes consumers are picky this holiday season * Shares fall nearly 6% premarket * Company beats Q3 sales estimates, posts surprise profit (Adds details on quarterly profit in paragraph 1, updates shares in paragraph 2, analyst comment in paragraph 4) By Juveria Tabassum Dec 3 (Reuters) - Macy's on Wednesday raised its annual targets for the second time...
BRIEF-Stepan Announces Agreement To Sell Lake Providence, LA Assets
BRIEF-Stepan Announces Agreement To Sell Lake Providence, LA Assets
Mar 10, 2026
Dec 3 (Reuters) - Stepan Co ( SCL ): * STEPAN ANNOUNCES AGREEMENT TO SELL LAKE PROVIDENCE, LA ASSETS * STEPAN CO ( SCL ): TERMS OF TRANSACTION WERE NOT DISCLOSED. Source text: Further company coverage: ...
Appian backs Atlantic Group buyout of Barrick gold mine in Côte d'Ivoire
Appian backs Atlantic Group buyout of Barrick gold mine in Côte d'Ivoire
Mar 10, 2026
ABU DHABI, United Arab Emirates, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Appian Capital Advisory Limited (“Appian”), the investment advisor to long-term value-focused private capital funds that invest in companies in metals, mining, and adjacent industries, announces the completion of a US$150 million acquisition financing package to Atlantic Group to support the buyout of Tongon gold mine in Côte d’Ivoire from...
Copyright 2023-2026 - www.financetom.com All Rights Reserved